Exchange: NASDAQ·Updated 03:44 PM EDT
PASG logo

PASGPassage Bio Inc

$5.58
$0.25
(4.69%)
Today
Reported EarningsMar 3
Mkt Cap$17.1M
Vol57,996.00

About

Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. The company was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
24

Frequently Asked Questions

What is Market Cap of Passage Bio Inc?
What is the 52-week high for Passage Bio Inc?
What is the 52-week low for Passage Bio Inc?
What is Passage Bio Inc stock price today?
What was Passage Bio Inc stock price yesterday?
What is the PE ratio of Passage Bio Inc?
What is the Price-to-Book ratio of Passage Bio Inc?
What is the 50-day moving average of Passage Bio Inc?
How many employees does Passage Bio Inc have?

Advertisement|Remove ads.